The company has successfully secured significant capital to fuel its expansion.
: Zenotech Laboratories (ZENOTECH) is a public company in India, but it is a separate entity. Deep Paper: Analyzing Zeno Health for Investment 1. Business Model & Growth Trajectory is zeno stock a good buy
: Currently generating approximately ₹250 crore ($30M USD) in revenue, with a target of ₹1,000 crore ($120M USD) within three years. 2. Financial Health & Funding The company has successfully secured significant capital to
: It bypasses supply chain bottlenecks by sourcing directly from manufacturers, allowing for competitive pricing of generic drugs. with a target of ₹1